Raportul
Analize aprofundate ale finanțării companiilor, strategiilor de creștere și informații de piață de la cele mai inovatoare afaceri din lume
4 rapoarte și mai multe
Zymergen Raises $575M in Series D
Zymergen, a Biotech company based in 5980 Horton Street, Emeryville, CA 94608, has raised $575M in Series D at a $3.2B valuation led by SoftBank Vision Fund, DCVC, True Ventures, Data Collective, Two Sigma Ventures.
Zymergen raises $130M Series C at $560M valuation
Zymergen raises $130M in Series C at $560M valuation. Bio-based materials and molecule development...
Zymergen raises $575M Series D at $3.2B valuation
Zymergen raises $575M in Series D at $3.2B valuation. Bio-based materials manufacturing...
Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation
Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.
Afișare 4 rapoarte • Pagina 1 • Categorie: all
Rămâneți înaintea pieței
Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.